“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about OmniAb, Inc
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics
| C-Level 2 | VP - Level8 |
| Director15 | Manager3 |
| Others38 | |
| Pain Points | Locations | Technologies |
|---|---|---|
| Application Development | Emeryville, CA | communication, cPLUSPLUS, java, collaboration, python |
| Digital Transformation | Emeryville, CA | communication, cPLUSPLUS, java, collaboration, python |
| Kernel engineering | Emeryville, CA | communication, cPLUSPLUS, java, collaboration, python |
| Support | Emeryville, CA | communication, cPLUSPLUS, java, collaboration, python |
| Web Development | Emeryville, CA | communication, cPLUSPLUS, java, collaboration, python |
Nice cxone
Access
Director
Excel
Ion
Assessment
Audit
Cloud computing
Collaboration
Communication
About OmniAbOmniAb provides our pharmaceutical industry partners access to the most diverse antib...
View MoreOmniAb, Inc. (NASDAQ: OABI) today announced that management will participate at the H.C. Wainwright 27th Annual Global Investment Conference taking place
Read MoreOmniAb Inc. (NASDAQ:OABI) presented its first quarter 2025 financial results and business update on May 8, 2025, highlighting revenue growth,
Read MoreOmniAb Inc. (NASDAQ:OABI) presented its first quarter 2025 financial results and business update on May 8, 2025, highlighting revenue growth,
Read MoreThe OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics
Omniab, inc operates in the Biotechnology research industry.
Omniab, inc's revenue is $26.39m
Omniab, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.